Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment

Monitoring renal function and adjusting dosing for patients with impaired renal function are not required with denosumab (60 mg every 6 months). However, these patients have an increased risk for developing hypocalcemia. This case report describes a patient with renal impairment who developed severe...

Descripción completa

Detalles Bibliográficos
Autor principal: Talreja, Draupadi B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2012
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980727/
https://www.ncbi.nlm.nih.gov/pubmed/27536425
http://dx.doi.org/10.3109/21556660.2012.668504
_version_ 1782447504811360256
author Talreja, Draupadi B.
author_facet Talreja, Draupadi B.
author_sort Talreja, Draupadi B.
collection PubMed
description Monitoring renal function and adjusting dosing for patients with impaired renal function are not required with denosumab (60 mg every 6 months). However, these patients have an increased risk for developing hypocalcemia. This case report describes a patient with renal impairment who developed severe hypocalcemia after receiving denosumab.
format Online
Article
Text
id pubmed-4980727
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-49807272016-08-17 Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment Talreja, Draupadi B. J Drug Assess Research Report Monitoring renal function and adjusting dosing for patients with impaired renal function are not required with denosumab (60 mg every 6 months). However, these patients have an increased risk for developing hypocalcemia. This case report describes a patient with renal impairment who developed severe hypocalcemia after receiving denosumab. Taylor & Francis 2012-02-21 /pmc/articles/PMC4980727/ /pubmed/27536425 http://dx.doi.org/10.3109/21556660.2012.668504 Text en © 2012 The Author(s). Published by Taylor & Francis http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Research Report
Talreja, Draupadi B.
Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment
title Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment
title_full Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment
title_fullStr Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment
title_full_unstemmed Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment
title_short Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment
title_sort severe hypocalcemia following a single injection of denosumab in a patient with renal impairment
topic Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980727/
https://www.ncbi.nlm.nih.gov/pubmed/27536425
http://dx.doi.org/10.3109/21556660.2012.668504
work_keys_str_mv AT talrejadraupadib severehypocalcemiafollowingasingleinjectionofdenosumabinapatientwithrenalimpairment

Ejemplares similares